All the sessions from Transform 2021 are available on-demand now. Watch now.

Biomimedica has raised $2.4 million in a first round for its joint-repair business.

VentureWire reported that Emergent Medical Ventures led the round. Other investors include Asset Management Co. and Life Science Angels.

Based in Santa Clara, Calif., Biomimedica was started earlier this year. The company is developing a synthetic cartilage called Cartigel for joint repair.


VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative technology and transact. Our site delivers essential information on data technologies and strategies to guide you as you lead your organizations. We invite you to become a member of our community, to access:
  • up-to-date information on the subjects of interest to you
  • our newsletters
  • gated thought-leader content and discounted access to our prized events, such as Transform 2021: Learn More
  • networking features, and more
Become a member